| Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with α-synuclein M Bisaglia, S Mammi, L Bubacco Journal of Biological Chemistry 282 (21), 15597-15605, 2007 | 325 | 2007 |
| Structural insights on physiological functions and pathological effects of±‐synuclein M Bisaglia, S Mammi, L Bubacco The FASEB Journal 23 (2), 329-340, 2009 | 192 | 2009 |
| A topological model of the interaction between α-synuclein and sodium dodecyl sulfate micelles M Bisaglia, I Tessari, L Pinato, M Bellanda, S Giraudo, M Fasano, ... Biochemistry 44 (1), 329-339, 2005 | 144 | 2005 |
| The reaction of α-synuclein with tyrosinase: Possible implications for Parkinson disease I Tessari, M Bisaglia, F Valle, B Samorì, E Bergantino, S Mammi, ... Journal of biological chemistry 283 (24), 16808-16817, 2008 | 136 | 2008 |
| Copper ions and Parkinson’s disease: why is homeostasis so relevant? M Bisaglia, L Bubacco Biomolecules 10 (2), 195, 2020 | 130 | 2020 |
| DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function N Plotegher, G Berti, E Ferrari, I Tessari, M Zanetti, L Lunelli, E Greggio, ... Scientific reports 7 (1), 40699, 2017 | 130 | 2017 |
| Probing the relationship between Gram-negative and Gram-positive S1 proteins by sequence analysis P Salah, M Bisaglia, P Aliprandi, M Uzan, C Sizun, F Bontems Nucleic acids research 37 (16), 5578-5588, 2009 | 110 | 2009 |
| Dopamine quinones interact with α-synuclein to form unstructured adducts M Bisaglia, L Tosatto, F Munari, I Tessari, PP de Laureto, S Mammi, ... Biochemical and Biophysical Research Communications 394 (2), 424-428, 2010 | 109 | 2010 |
| DJ-1 is a copper chaperone acting on SOD1 activation S Girotto, L Cendron, M Bisaglia, I Tessari, S Mammi, G Zanotti, ... Journal of Biological Chemistry 289 (15), 10887-10899, 2014 | 102 | 2014 |
| Anti-oxidants in Parkinson’s disease therapy: a critical point of view R Filograna, M Beltramini, L Bubacco, M Bisaglia Current Neuropharmacology 14 (3), 260-271, 2016 | 101 | 2016 |
| Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: implications for mitochondrial dysfunction in Parkinson disease M Bisaglia, ME Soriano, I Arduini, S Mammi, L Bubacco Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1802 (9), 699-706, 2010 | 98 | 2010 |
| Broken helix in vesicle and micelle-bound α-synuclein: Insights from site-directed spin labeling-EPR experiments and MD simulations M Bortolus, F Tombolato, I Tessari, M Bisaglia, S Mammi, L Bubacco, ... Journal of the American Chemical Society 130 (21), 6690-6691, 2008 | 92 | 2008 |
| Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease? M Bisaglia, R Filograna, M Beltramini, L Bubacco Ageing research reviews 13, 107-114, 2014 | 91 | 2014 |
| Pathogenic Mutations Shift the Equilibria of α‐Synuclein Single Molecules towards Structured Conformers M Brucale, M Sandal, S Di Maio, A Rampioni, I Tessari, L Tosatto, ... ChemBioChem 10 (1), 176-183, 2009 | 91 | 2009 |
| Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease A Biosa, F Sandrelli, M Beltramini, E Greggio, L Bubacco, M Bisaglia Neurobiology of disease 108, 65-72, 2017 | 88 | 2017 |
| Analysis of the catecholaminergic phenotype in human SH-SY5Y and BE (2)-M17 neuroblastoma cell lines upon differentiation R Filograna, L Civiero, V Ferrari, G Codolo, E Greggio, L Bubacco, ... PLoS one 10 (8), e0136769, 2015 | 86 | 2015 |
| Dopamine-derived quinones affect the structure of the redox sensor DJ-1 through modifications at Cys-106 and Cys-53 S Girotto, M Sturlese, M Bellanda, I Tessari, R Cappellini, M Bisaglia, ... Journal of Biological Chemistry 287 (22), 18738-18749, 2012 | 86 | 2012 |
| Interaction between α-synuclein and metal ions, still looking for a role in the pathogenesis of Parkinson’s disease M Bisaglia, I Tessari, S Mammi, L Bubacco Neuromolecular medicine 11, 239-251, 2009 | 86 | 2009 |
| Structure and topology of the non‐amyloid‐β component fragment of human α‐synuclein bound to micelles: Implications for the aggregation process M Bisaglia, A Trolio, M Bellanda, E Bergantino, L Bubacco, S Mammi Protein science 15 (6), 1408-1416, 2006 | 83 | 2006 |
| Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson’s disease E Belluzzi, M Bisaglia, E Lazzarini, LC Tabares, M Beltramini, L Bubacco PloS one 7 (6), e38026, 2012 | 82 | 2012 |
